Xtant Medical Holdings Stock Buy Hold or Sell Recommendation
| XTNT Stock | USD 0.91 0.07 8.33% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Xtant Medical Holdings is 'Strong Sell'. Macroaxis provides Xtant Medical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding XTNT positions. The advice algorithm takes into account all of Xtant Medical's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Xtant Medical's buy or sell advice are summarized below:
Real Value 1.08 | Target Price 1.35 | Hype Value 0.92 | Market Value 0.91 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Xtant Medical Holdings given historical horizon and risk tolerance towards Xtant Medical. When Macroaxis issues a 'buy' or 'sell' recommendation for Xtant Medical Holdings, the advice is generated through an automated system that utilizes algorithms and statistical models.
Xtant |
Execute Xtant Medical Buy or Sell Advice
The Xtant recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Xtant Medical Holdings. Macroaxis does not own or have any residual interests in Xtant Medical Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Xtant Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Xtant Medical Trading Alerts and Improvement Suggestions
| Xtant Medical generated a negative expected return over the last 90 days | |
| Xtant Medical has high historical volatility and very poor performance | |
| Xtant Medical has some characteristics of a very speculative penny stock | |
| Xtant Medical Holdings currently holds about 16.5 M in cash with (9.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Xtant Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 69.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from news.google.com: Xtant Medical Shares Cross Above 200 Day Moving Average of 0.00 - MarketBeat |
Xtant Medical Returns Distribution Density
The distribution of Xtant Medical's historical returns is an attempt to chart the uncertainty of Xtant Medical's future price movements. The chart of the probability distribution of Xtant Medical daily returns describes the distribution of returns around its average expected value. We use Xtant Medical Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Xtant Medical returns is essential to provide solid investment advice for Xtant Medical.
| Mean Return | -0.27 | Value At Risk | -8.14 | Potential Upside | 7.63 | Standard Deviation | 5.04 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Xtant Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Xtant Medical Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 692K | (5.8M) | 2.6M | (1.2M) | (1.9M) | (2.0M) | |
| Change In Cash | (1.6M) | (2.9M) | 16.0M | 2.1M | (14.6M) | (13.9M) | |
| Free Cash Flow | (1.3M) | (2.3M) | (1.7M) | (7.1M) | (11.0M) | (11.5M) | |
| Capital Expenditures | 879K | 1.5M | 2.1M | 1.8M | 1.5M | 1.6M | |
| Net Income | (8.2M) | (7.0M) | (4.8M) | (8.5M) | 660K | 693K | |
| End Period Cash Flow | 5.2M | 2.3M | 18.4M | 20.5M | 5.9M | 5.8M | |
| Depreciation | 3.1M | 2.1M | 1.3M | 1.3M | 3.2M | 3.1M | |
| Other Non Cash Items | 5.7M | 6.0M | 156K | 2.2M | (10.6M) | (10.0M) | |
| Net Borrowings | (603K) | (471K) | (592K) | (241K) | (216.9K) | (206.1K) | |
| Change To Netincome | 1.5M | 1.5M | 3.2M | 4.4M | 5.1M | 4.8M | |
| Investments | (544K) | (1.3M) | (1.9M) | (1.6M) | (22.9M) | (21.7M) | |
| Change Receivables | 2.5M | (647K) | 2.9M | (3.9M) | (3.5M) | (3.4M) |
Xtant Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Xtant Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Xtant Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Xtant stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.41 | |
β | Beta against NYSE Composite | 1.70 | |
σ | Overall volatility | 5.10 | |
Ir | Information ratio | -0.07 |
Xtant Medical Volatility Alert
Xtant Medical Holdings exhibits very low volatility with skewness of 0.27 and kurtosis of 1.44. Xtant Medical Holdings is a potential penny stock. Although Xtant Medical may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Xtant Medical Holdings. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Xtant instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Xtant Medical Fundamentals Vs Peers
Comparing Xtant Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Xtant Medical's direct or indirect competition across all of the common fundamentals between Xtant Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Xtant Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Xtant Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Xtant Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Xtant Medical to competition |
| Fundamentals | Xtant Medical | Peer Average |
| Return On Equity | 0.0154 | -0.31 |
| Return On Asset | -0.0831 | -0.14 |
| Profit Margin | 0.01 % | (1.27) % |
| Operating Margin | (0.14) % | (5.51) % |
| Current Valuation | 127.23 M | 16.62 B |
| Shares Outstanding | 130.22 M | 571.82 M |
| Shares Owned By Insiders | 8.30 % | 10.09 % |
| Shares Owned By Institutions | 69.27 % | 39.21 % |
| Number Of Shares Shorted | 280.58 K | 4.71 M |
| Price To Earning | (0.41) X | 28.72 X |
| Price To Book | 2.12 X | 9.51 X |
| Price To Sales | 1.19 X | 11.42 X |
| Revenue | 91.3 M | 9.43 B |
| Gross Profit | 32.14 M | 27.38 B |
| EBITDA | (6.98 M) | 3.9 B |
| Net Income | 660 K | 570.98 M |
| Cash And Equivalents | 16.5 M | 2.7 B |
| Cash Per Share | 0.19 X | 5.01 X |
| Total Debt | 23.56 M | 5.32 B |
| Debt To Equity | 0.60 % | 48.70 % |
| Current Ratio | 3.57 X | 2.16 X |
| Book Value Per Share | 0.39 X | 1.93 K |
| Cash Flow From Operations | (9.52 M) | 971.22 M |
| Short Ratio | 1.57 X | 4.00 X |
| Earnings Per Share | 0.01 X | 3.12 X |
| Price To Earnings To Growth | (0.03) X | 4.89 X |
| Target Price | 1.93 | |
| Number Of Employees | 207 | 18.84 K |
| Beta | 0.22 | -0.15 |
| Market Capitalization | 109.38 M | 19.03 B |
| Total Asset | 92.61 M | 29.47 B |
| Retained Earnings | (243.01 M) | 9.33 B |
| Working Capital | 41.88 M | 1.48 B |
Note: Acquisition by Sean Browne of 731632 shares of Xtant Medical subject to Rule 16b-3 [view details]
Xtant Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Xtant . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 7566.07 | |||
| Daily Balance Of Power | 0.875 | |||
| Rate Of Daily Change | 1.08 | |||
| Day Median Price | 0.87 | |||
| Day Typical Price | 0.88 | |||
| Price Action Indicator | 0.075 | |||
| Period Momentum Indicator | 0.07 |
About Xtant Medical Buy or Sell Advice
When is the right time to buy or sell Xtant Medical Holdings? Buying financial instruments such as Xtant Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 4.3M | 5.5M | 10.4M | 10.9M | Total Assets | 54.7M | 60.2M | 92.6M | 60.0M |
Use Investing Ideas to Build Portfolios
In addition to having Xtant Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Theme ETFs Thematic Idea Now
Theme ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Theme ETFs theme has 488 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Theme ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Xtant Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Xtant Stock analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Xtant Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xtant Medical. If investors know Xtant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xtant Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.01 | Revenue Per Share 0.767 | Quarterly Revenue Growth 0.841 | Return On Assets (0.08) | Return On Equity 0.0154 |
The market value of Xtant Medical Holdings is measured differently than its book value, which is the value of Xtant that is recorded on the company's balance sheet. Investors also form their own opinion of Xtant Medical's value that differs from its market value or its book value, called intrinsic value, which is Xtant Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xtant Medical's market value can be influenced by many factors that don't directly affect Xtant Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xtant Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xtant Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xtant Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.